Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-07 Purchase | 2023-11-09 8:36 pm | Lexeo Therapeutics Inc. | LXEO | Omega Fund VI L.P. Omega Fund VI GP L.P. Omega Fund VI GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari 10% Owner | 454,545 | $11 | $4,999,995 | 2,157,623 (Direct) | View |
| 2023-11-07 Purchase | 2023-11-09 8:33 pm | Lexeo Therapeutics Inc. | LXEO | Lundbeckfond Invest A/S 10% Owner | 227,272 | $11 | $2,499,992 | 1,835,959 (Direct) | View |
| 2023-11-07 Purchase | 2023-11-09 8:32 pm | Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 454,545 | $11 | $4,999,995 | 2,567,100 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-02-06 5:58 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | See Tai Sandi Chief Development Officer | 0 | $0 | 180,564 (Direct) | View |
| 2024-02-02 Option Award | 2024-02-06 5:58 pm | N/A 2034-02-01 | Lexeo Therapeutics Inc. | LXEO | DIAZ REINALDO M Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2024-02-02 Option Award | 2024-02-06 5:57 pm | N/A 2034-02-01 | Lexeo Therapeutics Inc. | LXEO | Agger Mette Kirstine Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2024-02-02 Option Award | 2024-02-06 5:56 pm | N/A 2034-02-01 | Lexeo Therapeutics Inc. | LXEO | Adler Eric Chief Medical Officer | 188,125 | $0 | 188,125 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 6:52 pm | N/A 2034-01-04 | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 306,250 | $0 | 433,195 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 6:50 pm | N/A 2034-01-04 | Lexeo Therapeutics Inc. | LXEO | Robertson Jenny Chief Legal and Admin Officer | 166,250 | $0 | 166,250 (Direct) | View |
| 2023-11-07 Conversion | 2023-11-09 8:36 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Omega Fund VI L.P. Omega Fund VI GP L.P. Omega Fund VI GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari 10% Owner | 19,318,610 | $0 | 2,157,623 (Direct) | View |
| 2023-11-07 Conversion | 2023-11-09 8:35 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | McCormac Paul Chief Technical Officer | 32,252 | $0 | 17,349 (Direct) | View |
| 2023-11-07 Conversion | 2023-11-09 8:33 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Lundbeckfond Invest A/S 10% Owner | 18,224,219 | $0 | 1,835,959 (Direct) | View |
| 2023-11-07 Conversion | 2023-11-09 8:32 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 24,018,702 | $0 | 2,567,100 (Indirect) | View |
Ownership | 2023-11-02 9:42 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer | 0 | $0 | 906,222 (Direct) | View |
Ownership | 2023-11-02 9:41 pm | N/A 2032-05-05 | Lexeo Therapeutics Inc. | LXEO | Robertson Jenny Chief Legal and Admin. Officer | 0 | $0 | 135,516 (Direct) | View |
Ownership | 2023-11-02 9:40 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Omega Fund VI L.P. Omega Fund VI GP L.P. Omega Fund VI GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari 10% Owner | 0 | $0 | 1,662,748 (Direct) | View |
Ownership | 2023-11-02 9:38 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | McCormac Paul Chief Technical Officer | 0 | $0 | 184,368 (Direct) | View |
Ownership | 2023-11-02 9:37 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Lundbeckfond Invest A/S 10% Owner | 0 | $0 | 1,568,357 (Direct) | View |
Ownership | 2023-11-02 9:36 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 0 | $0 | 2,067,743 (Indirect) | View |
Ownership | 2023-11-02 9:19 pm | N/A 2033-08-21 | Lexeo Therapeutics Inc. | LXEO | COOPERSTONE BRENDA Director | 0 | $0 | 59,812 (Direct) | View |
Ownership | 2023-11-02 9:17 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | CHOLMONDELEY PAULA H Director | 0 | $0 | 59,811 (Direct) | View |
Ownership | 2023-11-02 9:16 pm | N/A 2031-02-15 | Lexeo Therapeutics Inc. | LXEO | Altschuler Steven Director | 0 | $0 | 119,625 (Direct) | View |
Ownership | 2023-11-02 9:14 pm | N/A 2031-11-03 | Lexeo Therapeutics Inc. | LXEO | Adler Eric Chief Scientific Officer | 0 | $0 | 256,679 (Direct) | View |